74 filings
Page 3 of 4
8-K
2554z9 fv74
31 Jul 20
Other Events
5:02pm
8-K
yuo720b0
30 Jul 20
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
6:43am
8-K
bx1kmid6s
25 Jun 20
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
nbzso
13 Apr 20
Entry into a Material Definitive Agreement
9:01am
8-K
igccxls4q1h6dfv ad
29 Jan 20
Spring Bank Discontinues Development of Inarigivir for the Treatment of HBV
9:15am
8-K
v637yz5 xi1
26 Dec 19
Other Events
7:08am
8-K
d26ex8g
17 Oct 19
Other Events
9:15am
8-K
yxfv 39bx1znusupu6lq
4 Sep 19
Spring Bank Announces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance
8:30am
8-K
h0vtayw9hzlqx
10 Jul 19
Spring Bank Pharmaceuticals Announces Election of Pamela Klein, M.D., to its Board of Directors
4:15pm
8-K
iklpz7
12 Apr 19
Regulation FD Disclosure
8:00am
8-K
9z44nlz
18 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
oj7wfh5uue dz03q0
6 Nov 18
Regulation FD Disclosure
8:01am
8-K
t80b2wurwm2 rv5b
16 Aug 18
Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
4:00pm
8-K
ojaoqwvvecjz
9 Aug 18
Spring Bank Announces Proposed Public Offering of Common Stock
12:00am
8-K
rgbnk
2 Aug 18
Regulation FD Disclosure
8:00am
8-K
soo7uyik5fs
1 Aug 18
Spring Bank Pharmaceuticals Reports Second Quarter Financial Results
12:00am
8-K
w26ef tnn
19 Jun 18
Departure of Directors or Certain Officers
4:21pm
8-K
ulbn61cl
27 Apr 18
Spring Bank Pharmaceuticals Provides Corporate Update and Reports First Quarter Financial and Operational Results
9:15am
8-K
46sim6
25 Apr 18
Regulation FD Disclosure
9:15am
8-K
gw2s1wdp44ah4k
10 Apr 18
Spring Bank Announces Expanded Inarigivir Data from the ACHIEVE Trial to Be Presented at The International Liver CongressTM
12:00am